Author name: Yali Friedman

Merck Outlines Vioxx Defense At its annual meeting, Merck discussed its planned defense against the flood of lawsuits brought on […]

Survey Shows Lack of Confidence at FDA About two-thirds of Food and Drug Administration scientists are less than fully confident

Bill Aims to Protect Joint Patents Patents that result from collaboration between universities and companies won new protections from legal

Trouble for California Cloning? The United Nations will likely decide Friday, after many delays, whether to vote on an international

The Murky History of Merck’s Vioxx Merck’s decision to withdraw its popular arthritis drug Vioxx from the market in late

The Murky History of Merck’s Vioxx Merck’s decision to withdraw its popular arthritis drug Vioxx from the market in late

Contingency Plans Help Current Merck Crisis : In the wake of Merck & Co.’s announcement to pull Vioxx off the

Reviewing Drug Safety “The Food & Drug Administration has announced a major review of its system for monitoring the safety

The Stem Cell Gold Rush: Scientists around the country who study embryonic stem cells may be mourning four more years

Financial Snapshot For September 2004 In need of a boost.